Rein Therapeutics Inc (RNTX) Stock Analysis

Rein Therapeutics Inc (RNTX) is a publicly traded company in the HEALTHCARE sector. It trades at $1.03, carries a market capitalization of $91.53M. This page summarizes the public market data, fundamentals, and frequently asked questions for RNTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.03
• Market Cap: $91.53M
• EPS: $-1.90
• 52-Week High: $2.18
• 52-Week Low: $0.95

Market Sentiment

Rein Therapeutics Inc currently has a Bullish sentiment score of 0.21.

About Rein Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Rein Therapeutics Inc (RNTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RNTX.

Frequently Asked Questions

Does RNTX pay dividends?

Rein Therapeutics Inc (RNTX) does not currently pay a regular dividend.

What is RNTX's market cap?

Rein Therapeutics Inc (RNTX) has a market capitalization of $91.53M with a current stock price of $1.03.